Joining forces: first application of a rapamycin-induced dimerizable Cre system for conditional null mutant analysis in Leishmania. - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Molecular Microbiology Année : 2016

Joining forces: first application of a rapamycin-induced dimerizable Cre system for conditional null mutant analysis in Leishmania.

Résumé

Reverse genetics in Leishmania spp has gained importance beyond basic research as efforts increase to discover and validate new drug targets. Often, the most promising targets are essential for viability of the parasites, defying a genetic analysis by current gene replacement strategies. Duncan et al. demonstrate the applicability of DiCre recombination in Leishmania for induced replacement of the kinase CRK3 gene in promastigotes. DiCre gene replacement leads to the rapid loss of the gene and allows monitoring the phenotypic effects of the loss of function, eliminating the need for prolonged cultivation and selection. Implementation of the DiCre approach will allow functional genetics of the most important of Leishmania genes and is likely to boost genetic research and drug target discovery.

Domaines

Parasitologie
Fichier principal
Vignette du fichier
Commentary MMI-2015-15674 revised.pdf (365.79 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

pasteur-01440873 , version 1 (08-03-2021)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Gerald F Späth, Joachim Clos. Joining forces: first application of a rapamycin-induced dimerizable Cre system for conditional null mutant analysis in Leishmania.. Molecular Microbiology, 2016, 100 (6), pp.923-927. ⟨10.1111/mmi.13374⟩. ⟨pasteur-01440873⟩

Collections

INSERM PASTEUR
70 Consultations
63 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More